Seeking Alpha

Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, March 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (RWLK), (“ReWalk” or the “Company”), a leading provider of innovative technologies that ...
Seeking Alpha

ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Nov. 28, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics (RWLK), Ltd. ("ReWalk" or the "Company"), a leading provider of innovative technologies that ...
Nasdaq

Lifeward Ltd. Announces FDA Clearance for ReWalk 7 Exoskeleton Device

Lifeward Ltd. announced it has received 510(k) FDA clearance for its latest personal exoskeleton device, the ReWalk 7, which enables individuals with spinal cord injuries to stand and walk. This new ...
Nasdaq

Lifeward Ltd. Secures First Major U.S. Health Insurance Approval for ReWalk 7 Personal Exoskeleton, Paving the Way for Market Expansion

Lifeward announces approval for ReWalk 7 coverage by a major U.S. health insurer, enhancing access for individuals with spinal cord injuries. Approval for reimbursement by a major insurer comes ...